Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / France

Marie Skłodowska-Curie Action · Running

cisCODE Training a New Generation to Decode the Human Cis-Regulatory Genome

Coordinator
Institut National De La Sante Et De La Recherche Medicale, France
Runs
1 January 2027 to 31 December 2030
Status
Running
EU funding
€4.6m
Total cost
—
Partners
27 organisations in 12 countries
Type
Marie Skłodowska-Curie Action
Grant agreement
101312602

What the project is doing

In the project's own words, from its summary on CORDIS.

Decoding how the “non-coding” genome controls gene expression is one of the grand challenges of modern biomedicine. Most disease-associated variants fall in regulatory DNA, yet their effects on gene regulation remain largely unpredictable, limiting diagnosis, risk stratification and the design of safe gene and cell therapies. cisCODE is an MSCA Doctoral Network that will train 15 Doctoral Candidates to crack the cis-regulatory code by combining cutting-edge genomics with artificial intelligence and synthetic biology.

The network gathers 13 academic partners, completed with 9 non-academic partners across experimental and computational disciplines. Together, they will (i) decode the sequence “grammar” and modular function of cis-regulatory elements, (ii) map the rules of communication and compatibility between distal enhancers and promoters in three-dimensional chromatin, and (iii) build causal, predictive enhancer-based gene regulatory networks in health, stress, inflammation and cancer.

Doctoral projects will leverage single-cell multi-omics, high-throughput functional assays, advanced 3D genome profiling and next-generation AI models to move from descriptive catalogues to mechanistic and predictive understanding.cisCODE is also a training engine for Europe. A structured, international and intersectoral programme will provide Doctoral Candidates with personalised research and career development plans, network-wide schools, secondments in industry and clinics, and dedicated training in open science, data stewardship, ethics and innovation.

By delivering new models, datasets and synthetic regulatory tools openly to the community, cisCODE will accelerate interpretation of regulatory variants, support the rational design of precision therapies, and consolidate Europe’s leadership at the interface of regulatory genomics, artificial intelligence and personalised medicine.

Topics

Who is involved

OrganisationCityCountryRole
Institut National De La Sante Et De La Recherche MedicaleParisFranceCoordinator
Universitat WienWienAustriaParticipant
Katholieke Universiteit LeuvenLeuvenBelgiumAssociatedpartner
Vib VzwZwijnaarde - GentBelgiumParticipant
Alithea Genomics SACossonaySwitzerlandAssociatedpartner
Ecole Polytechnique Federale De LausanneLausanneSwitzerlandParticipant
Universitat BaselBaselSwitzerlandParticipant
Univerzita KarlovaPraha 1CzechiaAssociatedpartner
Ustav Molekularni Genetiky Av Cr V.v.i.Praha 4CzechiaParticipant
Lucid Genomics GbmHBerlinGermanyAssociatedpartner
Kobenhavns UniversitetKobenhavnDenmarkParticipant
Syddansk UniversitetOdense MDenmarkParticipant
Agencia Estatal Consejo Superior De Investigaciones CientificasMadridSpainParticipant
Fundacio Centre De Regulacio GenomicaBarcelonaSpainParticipant
Universidad De CantabriaSantanderSpainAssociatedpartner
Universidad Pompeu FabraBarcelonaSpainAssociatedpartner
KomNimesFranceAssociatedpartner
SadouniMarseilleFranceAssociatedpartner
Universite D'aix MarseilleMarseilleFranceAssociatedpartner
Istituto Europeo Di Oncologia SRLMilanoItalyParticipant
Universita Degli Studi Di MilanoMilanoItalyAssociatedpartner
Annogen B.V.AmsterdamNetherlandsAssociatedpartner
Vassilios TriantisAmsterdamNetherlandsAssociatedpartner
Instytut Biologii Doswiadczalnej Im. M. Nenckiego Polskiej Akademii NaukWarszawaPolandParticipant
Politechnika WarszawskaWarszawaPolandParticipant
Enhanc3D GenomicsCambridgeUnited KingdomAssociatedpartner
Imperial College of Science Technology and MedicineLondonUnited KingdomParticipant

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI